• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国炎症性肠病综述

Review of inflammatory bowel disease in China.

作者信息

Ye Lingna, Cao Qian, Cheng Jianfeng

机构信息

Gastroenterology Department, Hangzhou Xiasha Hospital, Zhejiang 310016, China.

Gastroenterology Department, Sir Run Run Shaw Hospital, Zhejiang University Medical College, Hangzhou, Zhejiang 310016, China.

出版信息

ScientificWorldJournal. 2013 Nov 14;2013:296470. doi: 10.1155/2013/296470.

DOI:10.1155/2013/296470
PMID:24348149
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3848381/
Abstract

Inflammatory bowel disease mainly consisting of ulcerative colitis and Crohn's disease has been rising gradually during the last two decades in China. In this review article, we provide the latest epidemiological trends in incidence, prevalence, and mortality of IBD patients in China and summarize the risk factors and genetic susceptibility of Chinese IBD patients. We also compare these characteristics to those of IBD patients in Western countries.

摘要

主要由溃疡性结肠炎和克罗恩病组成的炎症性肠病在过去二十年中在中国呈逐渐上升趋势。在这篇综述文章中,我们提供了中国炎症性肠病患者发病率、患病率和死亡率的最新流行病学趋势,并总结了中国炎症性肠病患者的风险因素和遗传易感性。我们还将这些特征与西方国家炎症性肠病患者的特征进行了比较。

相似文献

1
Review of inflammatory bowel disease in China.中国炎症性肠病综述
ScientificWorldJournal. 2013 Nov 14;2013:296470. doi: 10.1155/2013/296470.
2
Incidence and Prevalence of Inflammatory Bowel Disease across Asia.亚洲炎症性肠病的发病率和患病率。
Yonsei Med J. 2021 Feb;62(2):99-108. doi: 10.3349/ymj.2021.62.2.99.
3
A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.一项针对马来西亚吉隆坡单一三级医疗中心炎症性肠病患者发病率趋势、社会人口学和临床特征的四十年分析。
BMC Public Health. 2019 Jun 13;19(Suppl 4):550. doi: 10.1186/s12889-019-6858-2.
4
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.21 世纪全球炎症性肠病的发病率和流行率:基于人群的系统综述研究。
Lancet. 2017 Dec 23;390(10114):2769-2778. doi: 10.1016/S0140-6736(17)32448-0. Epub 2017 Oct 16.
5
A Systematic Review of Epidemiology and Risk Factors Associated With Chinese Inflammatory Bowel Disease.中国炎症性肠病相关流行病学及危险因素的系统评价
Front Med (Lausanne). 2018 Jun 19;5:183. doi: 10.3389/fmed.2018.00183. eCollection 2018.
6
Prevalence of inflammatory bowel disease in the Australian general practice population: A cross-sectional study.澳大利亚普通人群中炎症性肠病的流行情况:一项横断面研究。
PLoS One. 2021 May 27;16(5):e0252458. doi: 10.1371/journal.pone.0252458. eCollection 2021.
7
Epidemiology of inflammatory bowel disease in Asia.亚洲炎症性肠病的流行病学
Indian J Gastroenterol. 2007 Nov-Dec;26(6):285-9.
8
Perspectives of IBD China: Is Crohn's and Colitis Foundation Model a Solution to Health Care Issues for the Country?IBD 中国视角:克罗恩病和结肠炎基金会模式是否为国家医疗保健问题提供了一个解决方案?
Inflamm Bowel Dis. 2018 Apr 23;24(5):925-929. doi: 10.1093/ibd/izy056.
9
Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China.炎症性肠病的全球化:从英国和中国炎症性肠病的演变看问题。
Lancet Gastroenterol Hepatol. 2016 Dec;1(4):307-316. doi: 10.1016/S2468-1253(16)30077-2. Epub 2016 Nov 10.
10
Epidemiology of inflammatory bowel disease.炎症性肠病的流行病学
Med Clin North Am. 1990 Jan;74(1):1-12. doi: 10.1016/s0025-7125(16)30581-8.

引用本文的文献

1
β-sitosterol alleviates dextran sulfate sodium-induced experimental colitis via inhibition of NLRP3/Caspase-1/GSDMD-mediated pyroptosis.β-谷甾醇通过抑制NLRP3/半胱天冬酶-1/ Gasdermin D介导的细胞焦亡减轻葡聚糖硫酸钠诱导的实验性结肠炎。
Front Pharmacol. 2023 Oct 26;14:1218477. doi: 10.3389/fphar.2023.1218477. eCollection 2023.
2
Dietary Zinc Ameliorates TNBS-Induced Colitis in Mice Associated with Regulation of Th1/Th2/Th17 Balance and NF-κB/NLRP3 Signaling Pathway.膳食锌可改善三硝基苯磺酸诱导的小鼠结肠炎,与调节 Th1/Th2/Th17 平衡和 NF-κB/NLRP3 信号通路有关。
Biol Trace Elem Res. 2024 Feb;202(2):659-670. doi: 10.1007/s12011-023-03715-y. Epub 2023 May 30.
3
Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases.基于外泌体的骨靶向药物递送缓解炎症性肠病中破骨细胞性骨形成和骨丢失。
Cell Rep Med. 2023 Jan 17;4(1):100881. doi: 10.1016/j.xcrm.2022.100881. Epub 2023 Jan 4.
4
Trends in Worldwide Research in Inflammatory Bowel Disease Over the Period 2012-2021: A Bibliometric Study.2012 - 2021年全球炎症性肠病研究趋势:一项文献计量学研究
Front Med (Lausanne). 2022 May 19;9:880553. doi: 10.3389/fmed.2022.880553. eCollection 2022.
5
Nomogram to predict primary non-response to infliximab in patients with Crohn's disease: a multicenter study.预测克罗恩病患者对英夫利昔单抗原发性无反应的列线图:一项多中心研究
Gastroenterol Rep (Oxf). 2020 Nov 12;9(4):329-338. doi: 10.1093/gastro/goaa069. eCollection 2021 Aug.
6
Colonic Epithelial PHLPP2 Deficiency Promotes Colonic Epithelial Pyroptosis by Activating the NF-B Signaling Pathway.结肠上皮 PHLPP2 缺乏通过激活 NF-B 信号通路促进结肠上皮细胞焦亡。
Oxid Med Cell Longev. 2021 Aug 6;2021:5570731. doi: 10.1155/2021/5570731. eCollection 2021.
7
The four epidemiological stages in the global evolution of inflammatory bowel disease.炎症性肠病全球演变的四个流行病学阶段。
Nat Rev Gastroenterol Hepatol. 2021 Jan;18(1):56-66. doi: 10.1038/s41575-020-00360-x. Epub 2020 Oct 8.
8
Modified Sijunzi decoction in the treatment of ulcerative colitis in the remission phase: study protocol for a series of N-of-1 double-blind, randomised controlled trials.加味四君子汤治疗缓解期溃疡性结肠炎的系列 N-of-1 双盲随机对照试验研究方案。
Trials. 2020 May 12;21(1):396. doi: 10.1186/s13063-020-04315-0.
9
Foes or Friends? Bacteria Enriched in the Tumor Microenvironment of Colorectal Cancer.敌人还是朋友?在结直肠癌肿瘤微环境中富集的细菌
Cancers (Basel). 2020 Feb 6;12(2):372. doi: 10.3390/cancers12020372.
10
PD-L1 is required for human endometrial regenerative cells-associated attenuation of experimental colitis in mice.程序性死亡配体1(PD-L1)是人类子宫内膜再生细胞减轻小鼠实验性结肠炎所必需的。
Am J Transl Res. 2019 Aug 15;11(8):4696-4712. eCollection 2019.

本文引用的文献

1
First prospective, population-based inflammatory bowel disease incidence study in mainland of China: the emergence of "western" disease.中国内地首项基于人群的炎症性肠病发病研究:“西方”疾病的出现。
Inflamm Bowel Dis. 2013 Aug;19(9):1839-45. doi: 10.1097/MIB.0b013e31828a6551.
2
Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study.基于亚太克罗恩病和结肠炎流行病学研究结果的炎症性肠病的发病率和表型。
Gastroenterology. 2013 Jul;145(1):158-165.e2. doi: 10.1053/j.gastro.2013.04.007. Epub 2013 Apr 9.
3
Clinical study of the relationship between inflammatory bowel diseases and colorectal neoplasms.炎症性肠病与结直肠肿瘤关系的临床研究
J Dig Dis. 2009 May;10(2):113-7. doi: 10.1111/j.1751-2980.2009.00372.x.
4
Long-term follow-up of ulcerative colitis in the Chinese population.中国人群溃疡性结肠炎的长期随访
Am J Gastroenterol. 2009 Mar;104(3):647-54. doi: 10.1038/ajg.2008.74. Epub 2009 Feb 3.
5
An update on the epidemiology of inflammatory bowel disease in Asia.亚洲炎症性肠病流行病学的最新情况。
Am J Gastroenterol. 2008 Dec;103(12):3167-82. doi: 10.1111/j.1572-0241.2008.02158.x.
6
[An association between MICB 0106 allele and ulcerative colitis in Chinese Han in Hubei province].[湖北汉族人群中MICB 0106等位基因与溃疡性结肠炎的关联]
Zhonghua Nei Ke Za Zhi. 2008 Mar;47(3):213-6.
7
Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study.1986 - 2005年韩国首尔松坡 - 江东地区炎症性肠病的流行病学:一项韩国炎症性肠病研究(KASID研究)
Inflamm Bowel Dis. 2008 Apr;14(4):542-9. doi: 10.1002/ibd.20310.
8
Ulcerative colitis in China: retrospective analysis of 3100 hospitalized patients.中国溃疡性结肠炎:3100例住院患者的回顾性分析
J Gastroenterol Hepatol. 2007 Sep;22(9):1450-5. doi: 10.1111/j.1440-1746.2007.04873.x.
9
Epidemiology and clinical characteristics of ulcerative colitis in Chinese population: experience from a single center in Hong Kong.中国人群中溃疡性结肠炎的流行病学及临床特征:来自香港单中心的经验
J Gastroenterol Hepatol. 2008 Mar;23(3):406-10. doi: 10.1111/j.1440-1746.2007.05079.x. Epub 2007 Jul 9.
10
Clinical features and natural history of ulcerative colitis in Korea.韩国溃疡性结肠炎的临床特征与自然病史。
Inflamm Bowel Dis. 2007 Mar;13(3):278-83. doi: 10.1002/ibd.20015.